Mainz Biomed B.V.
General ticker "MYNZ" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.3M (TTM average)
Mainz Biomed B.V. does not follow the US Stock Market performance with the rate: -20.1%.
Estimated limits based on current volatility of 4.1%: low 1.11$, high 1.21$
Factors to consider:
- Total employees count: 52163 as of 2021
Short-term MYNZ quotes
Long-term MYNZ plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.53MM | $0.90MM | $0.89MM |
| Operating Expenses | $26.97MM | $27.54MM | $19.59MM |
| Operating Income | $-26.44MM | $-26.64MM | $-18.70MM |
| Non-Operating Income | $0.06MM | $0.35MM | $-2.96MM |
| Interest Expense | $0.29MM | $0.81MM | $1.08MM |
| R&D Expense | $3.66MM | $9.59MM | $5.84MM |
| Income(Loss) | $-26.39MM | $-26.30MM | $-21.65MM |
| Profit(Loss)* | $-26.45MM | $-26.30MM | $-21.65MM |
| Stockholders Equity | $14.10MM | $3.25MM | $6.05MM |
| Inventory | $0.18MM | $0.61MM | $0.37MM |
| Assets | $20.24MM | $15.41MM | $13.24MM |
| Operating Cash Flow | $-14.77MM | $-21.94MM | $-17.09MM |
| Capital expenditure | $0.66MM | $1.90MM | $0.25MM |
| Investing Cash Flow | $-0.66MM | $-1.90MM | $-0.20MM |
| Financing Cash Flow | $23.94MM | $14.23MM | $16.60MM |
| Earnings Per Share** | $-1.87 | $-1.62 | $-22.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.